In general, the present invention relates to cardiac assist systems and methods that help the heart pump blood by applying forces to the exterior of the heart. More particularly, the present invention relates to the structure of the cardiac assist systems and their methods of operation.
There are many instances when a heart needs assistance to maintain a proper blood flow in a patient. Often hearts that are diseased, failing, or have stopped need the application of a cardiac assist system to prevent a patient from dying. Furthermore, the proper mechanical massaging of the failing heart may have additional therapeutic implications for recovery. In the prior art, many cardiac assist systems pierce the heart and/or vascular system so as to have direct effect upon the patient's blood.
However, thromboembolic events, the need for anticoagulation, hemolysis, immune reactions, and infections, contribute significantly to morbidity and mortality of such cardiac assist systems. Accordingly, it is preferable that the pumping of the heart be assisted not by directly acting upon the blood but by applying forces to the external surfaces of the heart as the heart expands and contracts. In this manner, the heart pumps the blood without having to interrupt the natural flow of the blood. Furthermore, the proper force applications to the external surfaces of the heart may aid in the heart's recovery.
In the prior art, there are many constructs that surround the ventricles of the heart and apply forces to the ventricles. Such systems are typically designed to help the ventricles of the heart to empty. However, the heart is a complex organ that both empties and fills as it pumps. In order for a heart to pump blood effectively and efficiently, a heart often needs assistance in both filling and emptying. Additionally, proper mechanical forces applied to the heart which still has some pumping function can aid in the heart's diastolic and systolic function and facilitate more physiologic heart function during filling and emptying cycles of a heart.
In U.S. Pat. No. 3,455,298, Dr. George Anstadt introduced a cardiac assist device that assists a heart in both its systolic and diastolic cycles. The device, known in the medical industry as the Anstadt cup, is a cup-shaped construct that fits over the ventricles of the heart. The Anstadt cup has a stiff outer shell and an inflatable inner membrane. The outer shell and inflatable membrane are placed around the ventricles of the heart. When the inflatable membrane expands, the inflatable membrane compresses the heart, therein helping with the heart's emptying or its systolic function when native heart function is still present. When the membrane deflates, there is a negative pressure that is created between the tissue of the heart and the stiff outer shell. This negative pressure assists the heart in filling, or with its diastolic pump function, when native heart function is still present.
Although the Anstadt cup does assist in the heart's pump function, the assist is less than optimal. Likewise, since the inflatable membrane is positioned between a rigid shell and the heart, the forces that can be applied to the heart are not nuanced. When the heart has an inherent pump function, the heart does more than fill and empty. During the pumping cycle, the heart also elongates and contracts. Likewise, ventricular tissue also twists as it expands and contracts. A cardiac assist device that uses a rigid shell and non-ideal membrane characteristics has very limited ability to follow the heart surface as the heart elongates, contracts and/or twists. This is important to conditions where the heart has no pump function and is changing its conformation in response to the device's forces, as well as when the heart is exhibiting inherent pump function and the device is aiding in promoting physiologic diastolic and systolic pump function. As a result, some areas of the heart experience higher surface forces than they should be, and some areas experience less surface forces than they should be. The result is an application of forces that are a compromise between what is mechanically achievable and what is needed to properly follow the heart's natural strain dynamics during filling and emptying.
Computer imaging software has allowed intricate three dimensional understanding of the heart conformational changes which can be characterized in three dimensional strain analyses. In a similar manner, material strain characteristics of a device can be analyzed and constructed to best act on the heart's surface. The interactions of a device and the heart can then be further analyzed such as the displacements imposed on the heart tissue by forces from the device as the material interacts with the heart surface. What is needed is a device construct having membrane fixing behavioral properties, housing framework properties, and drive system regulation that combine to generate ideal compression and expansion forces over the heart's surface. The combined ideal effect of a cardiac assist device construct can then be further refined through controlling forces delivered by the drive system which can adjust for physiologic changes imposed by the cardiovascular system. While assumptions may be used to model such a cardiac system, they can significantly deviate from reality in the physiologic setting. The discoveries revealed in this patent application pertain to the identity of the most ideal strain characteristics of the device construct's shell and outer membrane that allow the heart to be mechanically compressed and expanded when driven by an appropriate drive system.
The discovered ideal strain characteristics can be objectively measured with respect to loads or forces delivered from the drive system when the device is not acting on the heart. The discovered ideal strain characteristics can also be objectively measured with respect to the loads delivered by the drive system while the device is acting on the heart or a model of the cardiovascular system. The discovered strain characteristics of the device construct can be defined using 3-dimensional analysis in either loaded or unloaded conditions. However, characterization in either one or two dimensional planes provides reasonable surrogates for more practical, objective strain analyses.
A need therefore exists for an improved cardiac assist system that has a flexible outer shell integrated with an ideal inner membrane which combine to optimize the filling and emptying forces applied to the heart's surface. In this manner, the forces applied to the heart can result in optimal pump function of the arrested heart as well as better assist the heart's native pump function and best enable the potential recovery of heart function. This need is met by the present invention as described and claimed below.
The present invention is a system and method of increasing the pumping efficiency of an individual's heart. The heart is scanned in vivo to determine an actual pumping efficiency for the heart. The actual pumping efficiency is compared to an optimal pumping efficiency of an equivalent healthy heart to determine a force assist profile. The force assist profile is the force profile that, if physically applied to the individual's heart, would assist the heart in pumping blood at an improved efficiency that is closer to the optimal pumping efficiency.
A cardiac assist device is created that will apply the force assist profile to the heart. The cardiac assist device is surgically inserted in vivo to physically affect the heart. The cardiac assist device embodies materials that exhibit strain characteristics during its elongation and shortening that facilitate the compression and expansion of the heart. The cardiac assist device utilizes material dynamics needed to track the heart's surface such that the strain dynamics of the cardiac assist device are optimized for the needs of the heart. This allows the cardiac assist device to foster the heart's natural conformational changes during compression and expansion and facilitates the cardiac assist device's ability to grip the heart during transfer of the compression and expansion forces imposed over the heart's surface. The cardiac assist device has an outer shell and at least one inflatable membrane that passes over the ventricles of the heart, wherein the inflatable membrane is inflated and deflated in accordance with a pressure profile provided by a pneumatic pump.
The outer shell embodies outer shell strain characteristics that are a function of dimensions and materials utilized by the outer shell. Each inflatable membrane embodies membrane strain characteristics that are a function of dimensions and materials utilized by the inflatable membrane. The force assist profile is a function of forces that are applied by the outer shell and the elastic inflatable membranes when acted upon the drive system pressure profile and the heart.
For a better understanding of the present invention, reference is made to the following description of exemplary embodiments thereof, considered in conjunction with the accompanying drawings, in which:
Although the present invention cardiac assist system and methodology can be embodied in many ways, only some exemplary embodiments are illustrated and described. The exemplary embodiments are being shown for the purposes of explanation and description. The exemplary embodiments are selected in order to set forth some of the best modes contemplated for the invention. The illustrated embodiments, however, are merely exemplary and should not be considered as limitations when interpreting the scope of the appended claims.
Referring to
The inflatable membranes 16 are attached to the interior of the outer shell 14 along a basal bond and an apical bond. The inflatable membranes 16 begin at the apical bond and extend upwardly to the basal bond. The center of the inflatable membrane 16 between the basal bond and the apical bond is considered the long axis of the inflatable membrane 16. The center of the inflatable membrane 16 perpendicular to the long axis is considered the short axis of the inflatable membrane 16. The basal bond attachment point is approximately at a distance below the open top of the cup assembly 12 that is approximately zero percent to five percent of the overall height H1. The inflatable membranes 16 are fabricated to embody specific strain characteristics that can be further customized to the needs of a particular patient's heart. The structure of the inflatable membranes 16 is described in co-pending U.S. patent application Ser. No. 18/150,746, the disclosure of which is herein incorporated by reference.
The inflatable membranes 16 are inflated by a pneumatic pump 15. The pneumatic pump 15 is programable and is supplied with a pressure profile 17. The programable pressure profile 17 inflates and deflates the membranes 16 in accordance with the best regular natural pumping rhythm of the heart 11, or with a best regular pumping rhythm should the heart 11 have stopped. The synchronization of the programable pressure profile 17 to the natural rhythm of a heart is disclosed in co-pending U.S. patent application Ser. No. 17/825,343 the disclosure of which is incorporated herein by reference.
One improvement embodied by the current cardiac assist system 10 is that the outer shell 14 is flexible and is made from elastomeric material 18. Accordingly, the outer shell 14 has the ability to elastically expand, contract, elongate, shorten and twist. The outer shell 14 has an annular shape with an unstressed inner diameter. The maximum width of the unstressed inner diameter of the outer shell 14 is selected to be approximately five percent larger than the maximum atrioventricular diameter of the heart 11. The elastomeric construction of the outer shell 14 enables the outer shell 14 to expand, contract, lengthen and shorten in response to physiologic changes in the cardiovascular system that alter blood pressure and flow seen within the heart. This better enables the outer shell 14 to facilitate the inflatable membranes 16 as the inflatable membranes 16 contract, expand, shorten, lengthen, and twist with the underlying heart 11 as they move through a heart pumping cycle.
Referring to
The dynamics of heart contraction and expansion are highly complex. Different areas of the heart 11 expand and contact to different degrees at different times. In
Referring to
The flexible membrane 16 embodies various strain characteristics in the radial and tangential directions. Likewise, the outer shell 14 embodies additional strain characteristics in the radial and tangential directions. Together, the strain characteristics embodied by both the outer shell 14 and the inflatable membrane 16 can be customized to assist the heart 11 to fill and empty more effectively, should different disease states require. The ideal strain characteristics discovered in this application relate to a generally normal sized human heart with generally normal anatomic features and construct.
Referring to
The forces applied by the inflatable membranes 16 are directly applied to the exterior surface of the heart 11. The force dynamics applied by each inflatable membrane 16 is determined by the strain characteristics of the inflatable membrane 16 and the pressure profiles of the pneumatics being supplied to the inflatable membranes 16. The strain characteristics of the inflatable membrane 16 are also determined by the shape, size, material, and wall thicknesses of the membranes, as described in co-pending U.S. patent application Ser. No. 18/160,963, which has previously been incorporated by reference.
Referring to
As previously stated, as the inflatable membranes 16 are inflated, the inflatable membranes 16 stretch in a radial direction and in a tangential direction. Referring to
LA(x1)=K*[−2E−08x16+4E−06x15−0.0003x14+0.0132x13−0.2748x12+3.3624x1+2.2423] Equation 1
The displacement in the short axis is determined using the following equation:
SA(x2)=K*[−8E−06x24+0.001x23−0.0529x22+1.5781x2−0.2884] Equation 2
In equation 1 and equation 2, (K*) is a conversion factor that is dependent upon the inflation pressure differential (p), where:
K(P)=(6.9725 ln(P)+5.0464)/32.43
Accordingly, it will be understood that displacements in the radial and tangential directions are directly affected by inflation pressure. Changes in inflation pressure over time constitute the pressure profile provided to the inflatable membranes 16.
Referring to
Returning to
By selectively altering the material and/or localized thicknesses of the inflatable membranes 16, a multitude of membrane strain characteristics can be obtained. Likewise, by altering the material and/or area thicknesses of the outer shell 14, a multitude of outer shell strain characteristics can be obtained. Both the strain characteristics of the inflatable membranes 16 and the strain characteristics of the outer shell 14 react to the pressure profile supplied to the inflatable membrane 16 at any given point in time.
In
Referring to
The reduced pressure between the heart 11 and the outer shell 14 also acts to contract the outer shell 14. The outer shell 14 yields slightly but is stiff enough to resist being pulled against the expanding heart 11 with a resiliency force Fres. Accordingly, the forces that help the heart 11 expand are functions of the elastic strain characteristics of the outer shell 14, the elastic strain characteristics of the inflatable membrane 16 and the pneumatic pressure profile used to pressurize the inflatable membranes 16.
Referring to
Using the velocity vectors 51, a variety of data groups can be obtained that are useful in determining if the cardiac assist device in use is proper and effective. Changes in velocity vectors 51 at any point over time can be used to determine strain rate. In
Referring to
Once the pumping deficiencies of the heart 11 are known, an optimal force assist profile 21 is calculated. The force assist profile 21 determines what degrees of force need to be applied to different areas (A1-An) of the heart 11 during the diastolic and systolic cycles to assist the heart 11 in pumping without further damaging the heart 11. Once the force assist profile 21 is determined, software 20 is used to mix and match the possible outer shell strain characteristics 22, the possible membrane strain characteristics 24, and different pressure profiles 26. The software 20 mixes and matches the profile data until composite strain characteristics 28 are found that best matches the optimal force assist profile 21 required by the heart 11. See Block 44. Once the proper composite strain characteristics 28 are determined, the data is used to fabricate or select a proper cup assembly 12 and to select the proper pump control settings. See Block 46 and Block 48. The pump control settings are used to program the pneumatic pump 15 wherein the pneumatic pump 15 generates the selected pressure profile 26 utilized by the software 20.
Once the cup assembly 12 is installed, the effects of the cup assembly 12 on the heart 11 are monitored. If the effects on the heart 11 in vivo do not match the optimal force profile offered by the cup assembly, then the pump control settings can be adjusted. If the pump control settings are inadequate to correct any deficiencies, the cup assembly 12 is replaced.
Referring to
Referring to
Referring to
In
Referring to
The use of a single pressure tube 80 is highly advantageous since it is much less cumbersome than using multiple leads. In this manner, there is greater visibility during surgery and more room in which a surgeon can manipulate his/her hands and instruments.
Referring now to
It will be understood that the embodiments of the present invention that are illustrated and described are merely exemplary and that a person skilled in the art can make many variations to those embodiments. All such embodiments are intended to be included within the scope of the present invention as defined by the claims.
This application is a continuation-in-part of co-pending U.S. application Ser. No. 17/825,343 filed May 26, 2022, which is a continuation-in-part of U.S. application Ser. No. 17/208,776 filed Mar. 22, 2021, now U.S. Pat. No. 11,383,076, which claimed the benefit of U.S. Provisional Application No. 63/086,478 filed Oct. 1, 2020. This application is also a continuation-in-part of U.S. application Ser. No. 18/150,746 filed Jan. 5, 2023, which is a continuation-in-part of U.S. application Ser. No. 17/931,853 filed Sep. 13, 2022. This application is a further continuation-in-part of U.S. patent application Ser. No. 18/160,963, filed Jan. 27, 2023. This application is yet a further continuation-in-part of U.S. application Ser. No. 18/447,786 filed Aug. 10, 2023.
Number | Date | Country | |
---|---|---|---|
63086478 | Oct 2020 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 17825343 | May 2022 | US |
Child | 18509260 | US | |
Parent | 17208776 | Mar 2021 | US |
Child | 17825343 | US | |
Parent | 18150746 | Jan 2023 | US |
Child | 17208776 | US | |
Parent | 17931853 | Sep 2022 | US |
Child | 18150746 | US | |
Parent | 18160963 | Jan 2023 | US |
Child | 17931853 | US | |
Parent | 18447786 | Aug 2023 | US |
Child | 18160963 | US |